Alnylam Pharmaceuticals
ALNY
#817
Rank
A$44.29 B
Marketcap
A$331.02
Share price
0.23%
Change (1 day)
-51.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company